The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors
Conclusions:
These findings suggest the usefulness of VEGF in the early diagnostics of ovarian cancer, especially in combination with CA125 and HE4, as a new biomarkers panel. Additionally, VEGF is the most useful tool in the diagnostics of locally advanced ovarian cancer without metastases. Investigated cytokine presented similar to HE4 usefulness in differentiation of OC according to its histopathlogical sub-type, and could be used especially in the diagnostics of endometrioid epithelial OC.
Source: Journal of Ovarian Research - Category: Cancer & Oncology Authors: S¿awomir ¿awickiGra¿yna B¿dkowskaEwa Gacuta-SzumarskaMaciej Szmitkowski Source Type: research
More News: Cancer | Cancer & Oncology | Endometrial Cancer | Epithelial Cancer | Ovarian Cancer | Ovaries | Study